CS Paper Radar

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang

cs.LG eess.SY ·submitted 2026-09-10 22:42 UTC · v1
publishedbenchmark

Abstract

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

Comment
6 pages. Published in the 2026 American Control Conference (ACC)
Journal ref
2026 American Control Conference (ACC), pp. 1203-1208, 2026

Closest papers

Nearest neighbours by meaning across the whole index.

Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty

cs.LG ·2026-10-15 ·Chengze Xie, Xuan Wang, Ying Ding, Hairong Wang, Yan Li
similarity 0.76
Abstract

We develop a robust reinforcement learning (RL) framework for learning adaptive treatment policies that generalize across patients and remain reliable under errors in the measured biomarker and shifts in the disease dynamics. By modeling the patient as a hidden context, we address generalization and robustness in a unified manner through robust contextual Markov decision processes. Applying our framework to adaptive therapy for metastatic prostate cancer in a simulator calibrated to clinical data, we obtain generalizable and robust policies that substantially outperform the existing adaptive therapy method. In particular, we attain robustness with almost no loss of performance when the biomarker is accurate and the disease evolves as anticipated, and find that the resulting policy Pareto-dominates the existing method across a diverse array of scenarios. Our findings suggest that robust RL holds great promise as a principled methodology for learning reliable adaptive treatment policies.

0.17

Behavioral Cloning Outperforms Entropy-Regularized RL: Critic-Driven Failure of Actor-Critic Methods on Adaptive Tumor Treatment

cs.LG ·2026-09-06 ·Aleksandar Dimitrov, Giacomo Spigler
similarity 0.75
Abstract · 9 pages, 3 figures

Adaptive dosing requires policies that reduce tumor burden without excessive toxicity. Learned dosing policies are typically judged against historical or heuristic comparators, which cannot show whether a policy has found the best behavior available. We instead study a three-population tumor-control ODE in which optimal-control analysis fixes the form of a good schedule -- bang-bang dosing punctuated by a singular arc -- and construct a numerical controller of that form as a proxy for near-optimal behavior. Judged against this reference under a sustained-cure criterion -- 200 consecutive days below 5% carrying capacity -- Soft Actor-Critic (SAC) trained from scratch never reaches cure. Behavioral cloning (BC) of the reference reproduces it (100% sustained cure, 30/30 seeds), but SAC fine-tuning of the cloned policy destroys it across five entropy coefficients, and TD3 and BC-regularized SAC fail identically; the pattern persists under multiplicative pharmacokinetic action noise. Along curative trajectories the post-collapse critic ranks the collapsed-policy action above the reference action in 96% of states, concentrated in the maintenance phase, and the policy settles into a non-curative adaptive-therapy equilibrium. The reference is what makes this legible: against a heuristic comparator the fine-tuned policy would read as a competent controller rather than a failure.

0.29

Reinforcement Learning based control of Cancer Chemotherapy treatments

cs.AI cs.LG ·2026-11-06 ·Jayakody Kankanamalage Chamani Shiranthika
similarity 0.73
Abstract · Masters thesis at the National Taipei University. Received the IEEE Taipei Section, Best Masters thesis award in 2021

Reinforcement Learning has achieved tremendous success in recent years. Extending its scope from the traditional complex games such as Atari, Go, Pokeman, and Chess, reinforcement learning has caught researchers' attention on modelling real-life scenarios. Personalized medicine and the dynamic treatment regimen are two such preliminary research fields; researchers are focusing their mindsets currently. Estimating the optimal dynamic treatment regimens from the observational real clinical data is being popularized among the researchers, widening its scope towards more advanced versions of reinforcement learning algorithms. This research is about a research study that focused on reinforcement learning techniques that have been approached in the context of cancer chemotherapy treatments. Primarily this thesis addresses the result of the study by means of the state-of-the-art on reinforcement learning techniques used in generating the optimal policy for sequential treatments, including the existing online reinforcement learning approaches. Thereby a simulation for cancer chemotherapy via traditional Q-learning would be presented. Secondly, the study will extend towards using offline reinforcement learning in the optimal policy generation. Thus, the proposed solution follows a data-driven approach, which works on the real human colon cancer clinical data. The novelty of the proposed solution resides in the implementation of an offline reinforcement learning approach by means of a model-based architecture using the conservative Q-learning and the model-based offline policy optimization algorithm. As per the experimental results and the evaluations, it was revealed that the proposed Chemo RL model caters well the problem of cancer chemotherapy treatment scheduling and serves as a supportive model for the junior oncologists in deciding their treatment decisions.

0.10

Transformer-Based Reinforcement Learning for Phase I Dose Allocation

cs.LG stat.MLstat.AP ·2026-10-30 ·Shijie Yuan
similarity 0.69
Abstract

Phase I dose-finding trials must learn from sparse toxicity observations while limiting exposure to overly toxic doses. We develop a single reinforcement-learning policy for trials with different numbers of ordered dose levels. Each dose is represented as a token containing its normalized position, accumulated patient count, observed dose-limiting toxicities (DLTs), and current-dose indicator. A Transformer encoder summarizes the dose tokens, trial-conditioned cross-attention produces a fixed-dimensional trial representation, and a three-action policy chooses de-escalation, staying, or escalation. The final maximum tolerated dose (MTD) decision is deliberately kept outside the learned policy: after the planned sample size, weighted isotonic regression and a prespecified safety cap select the dose closest to the target toxicity probability. In the simulations, toxicity-penalized policies reduce DLT burden while unpenalized policies improve selection accuracy at the cost of greater toxicity. These results demonstrate a controllable safety--accuracy trade-off but do not establish superiority over conventional dose-finding designs.

0.16

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

cs.CV cs.LG ·2026-10-17 ·Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He
similarity 0.67
Abstract · 30 pages,8 figures,12 tables,including supplementary material

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

0.33

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.66
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

Last-Iterate Guarantees for Online Reinforcement Learning in Structured Constrained MDPs

cs.LG ·2026-09-26 ·Nam Phuong Tran, Trinh Ha Mai Huynh, Tuyen Pham Le, Van-Truong Nguyen, Quan Nguyen +1 more
similarity 0.64
Abstract

In safety-critical applications, deployment uses a single policy, whose performance and constraint satisfaction should hold directly rather than only for an average or mixture of training policies. This motivates last-iterate guarantees in constrained reinforcement learning. Recent progress has established such guarantees in exact-gradient or tabular online settings, yet scalable results for structured large-state problems remain open. We develop a general, statistically efficient framework for last-iterate convergence in structured Constrained MDPs (CMDPs). Our analysis separates contraction of the regularised primal-dual dynamics from actor approximation and statistical errors in policy evaluation under online exploration. This enables model-free on- and off-policy learning with structured function approximation: optimistic policy evaluation avoids explicit transition-model construction, while a compact parametric actor avoids maintaining mixtures or histories of past policies. We instantiate the framework for linear CMDPs and general function approximation, obtaining representation-dependent complexity and improved target-accuracy dependence over prior optimistic regularised primal-dual analyses. We further validate the stabilising effect predicted by our theory on a synthetic linear CMDP: the regularised method exhibits stable last-iterate behaviour, whereas its unregularised counterpart shows larger oscillations.

0.17

Safe Learning of Adaptive Control Policies for Remote Patient Monitoring

eess.SY ·2026-10-07 ·Ramanan Tamizholi, Siddharth Chandak, Isha Thapa, Nicholas Bambos, David Scheinker
published similarity 0.64
Abstract · Accepted at IEEE Healthcom 2026

Remote Patient Monitoring (RPM) enables continuous observation of patients in their daily environments, improving both health outcomes and quality of life. A key challenge in RPM is determining the optimal monitoring intensity, while balancing patient safety and monitoring costs. This problem is further complicated when system parameters, such as transition probabilities and costs, are initially unknown. We develop a learning-based control framework that estimates these parameters and adapts the monitoring policy in real time. The proposed approach is an online model-based reinforcement learning algorithm tailored to RPM, with patient safety explicitly prioritized during exploration. We provide theoretical guarantees on safety and convergence to the optimal policy. Simulation results show that the algorithm converges to the optimal threshold-based policy, maintains low treatment costs, and reduces the risk of patients reaching critical health states.

0.42